GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Getinge AB (OSTO:GETI B) » Definitions » Sale Of Investment

Getinge AB (OSTO:GETI B) Sale Of Investment : kr0 Mil (TTM As of Mar. 2024)


View and export this data going back to 1998. Start your Free Trial

What is Getinge AB Sale Of Investment?

Getinge AB's sale of investment for the three months ended in Mar. 2024 was kr0 Mil. It means Getinge AB gained kr0 Mil from selling investments. Getinge AB's sale of investment for the trailing twelve months (TTM) ended in Mar. 2024 was kr0 Mil.

Compared with last quarter (kr0 Mil in Dec. 2023 ), Getinge AB gained the same money from selling investments in Mar. 2024 (kr0 Mil).

Getinge AB Sale Of Investment Historical Data

The historical data trend for Getinge AB's Sale Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Getinge AB Sale Of Investment Chart

Getinge AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Sale Of Investment
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Getinge AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Sale Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Getinge AB Sale Of Investment Calculation

Sale of Investments represents cash inflow on the sale of investments in securities.

Sale Of Investment for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Getinge AB Sale Of Investment Related Terms

Thank you for viewing the detailed overview of Getinge AB's Sale Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.

Getinge AB (OSTO:GETI B) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Getinge AB (OSTO:GETI B) » Definitions » Sale Of Investment
Comparable Companies
OSTO:SECT B OSTO:VITR OSTO:XVIVO OSTO:CEVI OSTO:MCAP OSTO:BICO OSTO:BACTI B OSTO:SEDANA OSTO:CRAD B OSTO:INTEG B TSE:5212 ABT SYK MDT BSX EW DXCM SZSE:300760 ZBH ALGN
Traded in Other Exchanges
GNGBY:USA GNGBF:USA GETIBs:UK 0GZV:UK GTN:Germany
Address
Lindholmspiren 7A, P.O. Box 8861, Gothenburg, SWE, SE-417 56
Website
https://www.getinge.com
Getinge, headquartered in Gothenburg, Sweden, manufactures a wide range of products for use in acute care, surgical, and life sciences in the hospital, pharmaceutical, and research settings. The company reports in three segments: acute care therapies (54% of revenue), surgical workflows (32%), and life sciences (14%). Product areas include ventilators, surgical stents, life support systems, sterilizers, surgical tables, and sterile transfer systems. Getinge derives revenue from a broad geographic footprint, with the Americas accounting for 45% of sales (U.S. 33% of sales), Asia-Pacific 25%, and Europe, Middle East, and Africa the remaining 30%.

Getinge AB (OSTO:GETI B) Headlines

No Headlines